| DIANA-miRPath v4. 0: expanding target-based miRNA functional analysis in cell-type and tissue contexts S Tastsoglou, G Skoufos, M Miliotis, D Karagkouni, I Koutsoukos, ... Nucleic Acids Research 51 (W1), W154-W159, 2023 | 16 | 2023 |
| PlasmiR: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value S Tastsoglou, M Miliotis, I Kavakiotis, A Alexiou, EC Gkotsi, ... Cancers 13 (15), 3680, 2021 | 12 | 2021 |
| DIANA-mAP: Analyzing miRNA from Raw NGS Data to Quantification A Alexiou, D Zisis, I Kavakiotis, M Miliotis, A Koussounadis, D Karagkouni, ... Genes 12 (1), 46, 2021 | 12 | 2021 |
| Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality A Madè, S Greco, M Vausort, M Miliotis, E Schordan, S Baksi, L Zhang, ... Scientific Reports 12 (1), 20048, 2022 | 9 | 2022 |
| TarBase-v9. 0 extends experimentally supported miRNA–gene interactions to cell-types and virally encoded miRNAs G Skoufos, P Kakoulidis, S Tastsoglou, E Zacharopoulou, V Kotsira, ... Nucleic Acids Research 52 (D1), D304-D310, 2024 | 6 | 2024 |
| Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy R Chitalia, M Miliotis, N Jahani, S Tastsoglou, ES McDonald, V Belenky, ... Communications Medicine 3 (1), 46, 2023 | 4 | 2023 |
| Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells PE Nikolaou, N Mylonas, M Miliotis, I Kostopoulos, A Georgoulis, ... European Heart Journal 44 (Supplement_2), ehad655. 3119, 2023 | | 2023 |
